Onward Med Nv (ONWRF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by. Welcome to the Onward Medical Full Year 2025 Financial Results and Business Update. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you would need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would like now to turn the conference over to Sebastian Cross, Vice President of Communications. Please go ahead. Thank you, Michelle. Good morning, good afternoon, everyone, and welcome to Onward Webcast, following the publication of our full year results earlier today. Before we get started, as usual, please take a moment to read our disclaimer. Today's presentation includes forward-looking statements which should be considered with the appropriate level of caution as outlined on this page. This presentation and a recording of the webcast will be made available on our investor website after the call. With us today are three members of Onward's leadership team, Dave Marber, CEO, Ali Kiboro, our CFO, and Sherry O'Quinn, Chief Clinical Regulatory and Quality Officer. Today, we will present a comprehensive business update before opening the floor to questions. You may submit those already or via the Q&A module of the platform. With that, I'll hand over to Dave. Thank you, Seb, and thank you all all of you who have joined us today. 2025 was a really good year for Onward. I've been doing this for three decades now as a med tech leader, and it's really rare and exceptional to introduce a new technology and penetrate 80 clinics in your ...